Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies
A new diagnosis of type 1 diabetes (T1D) may be accompanied by numerous lifelong financial, emotional, and physical challenges, thus advancements in therapies that can delay the onset of clinical disease are crucial. T1D is an autoimmune condition involving destruction of pancreatic beta cells leadi...
Saved in:
Main Authors: | Alexander J. O’Donovan, Seth Gorelik, Laura M. Nally |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-11-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1477101/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies
by: Alexander J. O’Donovan, et al.
Published: (2025-01-01) -
Prevalence and factors associated with school failure in children with type 1 diabetes
by: Sawsen Nouira, et al.
Published: (2024-03-01) -
The usefulness of the T1DDS simulator in the context of multi-day type 1 diabetes therapy
by: Tomasz Nowicki
Published: (2024-12-01) -
Clinical and Biochemical Features Used to Classify Type-1 and Type-2 Diabetes: A Scoping Review
by: Ulagamadesan Venkatesan, et al.
Published: (2024-04-01) -
Snap diagnosis of fulminant type 1 diabetes by the normalized glucose/HbA1c ratio
by: Jun-Ichiro Mori, et al.
Published: (2024-11-01)